Buprenorphine and major metabolites in blood specimens collected for drug analysis in law enforcement purposes

Forensic Science International

Volumn 195, Issue 1-3, 2010, Pages 73-77

  Oechsler, Stephanie ^a   Skopp, Gisela ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Authentic samples; Buprenorphine; Glucuronides; LC ESI MS MS; Norbuprenorphine

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE 3 BETA GLUCURONIDE; CANNABIS; DRUG METABOLITE; GLUCURONIDE; MORPHINE; NORBUPRENORPHINE; NORBUPRENORPHINE 3 BETA GLUCURONIDE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; BLOOD SAMPLING; DRUG DETERMINATION; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; LAW ENFORCEMENT; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEPARATION TECHNIQUE; SOLID PHASE EXTRACTION;

EID: 74749093658     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2009.11.015     Document Type: Article

References (22)

1. Garrett E.R., and Chandran V.R. Pharmacokinetics of morphine and its surrogates X: analyses and pharmacokinetics of buprenorphine in dogs. Biopharm. Drug Dispos. 11 (1990) 311-350
2. Huang W., Moody D.E., and McCance-Katz E.F. The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid chromatography-electrospray ionization-tandem mass spectrometry. Ther. Drug Monit. 28 (2006) 245-251
3. Lufty K., and Cowan A. Buprenorphine: a unique drug with complex pharmacology. Curr. Neuropharmacol. 2 (2004) 395-402
4. Bomsien S., Aderjan R., Mattern R., and Skopp G. Effect of psychotropic medication on the in vitro metabolism of buprenorphine in human cDNA-expressed cytochrome P450 enzymes. Eur. J. Clin. Pharmacol. 62 (2006) 639-643
5. Cone E.J., Gorodetzky C.W., Yousefnejad D., Buchwald W.F., and Johnson R.E. The metabolism and excretion of buprenorphine in humans. Drug Metab. Dispos. 12 (1984) 577-581
6. Chang Y., and Moody D.E. Glucuronidation of buprenorphine and norbuprenorphine by human liver microsomes and UDP-glucuronosyltransferases. Drug Metab. Lett. 3 (2009) 101-107
7. Concheiro-Guisan M., Shaklea D.M., and Huestis M.A. Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in human placenta by liquid chromatography mass spectrometry. Anal. Bioanal. Chem. 394 (2009) 513-522
8. Murphy C.M., and Huestis M.A. Liquid chromatography/electrospray ionization tandem mass spectrometric analysis for the quantification of buprenorphine, norbuprenorphine, buprenorphine-3-β-d-glucuronide and norbuprenorphine-3-β-d-glucuronide in human plasma. J. Mass Spectrom. 40 (2005) 70-74
9. Deutsches Institut für Normung, DIN 32645 Nachweis-, Erfassungs- und Bestimmungsgrenze. Berlin, Beuth, 2008.
10. Matuszewski B.K., Constanzer M.L., and Chavez-Eng C.M. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 75 (2003) 3019-3030
11. Federal Drug Commissioner: Drugs and addiction report, 2009, p. 76.
12. Michels I.I., Stöver H., and Gerlach R. Substitution treatment for opioid addicts in Germany. Harm Reduc. 4 (2007) 5
13. Vincent F., Bessard J., Vacheron J., Mallaret M., and Bessard G. Determination of buprenorphine and norbuprenorphine in urine and hair by gas chromatography-mass spectrometry. J. Anal. Toxicol. 23 (1999) 270-279
14. Polettini A., and Huestis A. Simultaneous determination of buprenorphine, norbuprenorphine, and buprenorphine-glucuronide in plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 754 (2001) 447-459
15. Grimm D., Pauly E., Pöschl J., Linderkamp O., and Skopp G. Buprenorphine and norbuprenorphine concentrations in human breast milk samples determined by liquid chromatography-tandem mass spectrometry. Clin. Pharmacokinet. 44 (2005) 661-680
16. Kacinko S.L., Shakleya D.M., and Huestis M.A. Validation and application of a method for the determination of buprenorphine, norbuprenorphine, and their glucuronide conjugates in human meconium. Anal. Chem. 80 (2008) 245-252
17. Skopp G., Pötsch L., Klingmann A., and Mattern R. Stability of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in fresh blood and plasma and postmortem blood samples. J. Anal. Toxicol. 25 (2001) 2-7
18. Moody D.E., Slawson M.H., Strain E.C., Laycock J.D., Spanbauer A.C., and Foltz R.L. A liquid chromatographic-electrospray ionization-tandem mass spectrometric method for determination of buprenorphine, its metabolite, norbuprenorphine, and a coformulant, naloxone, that is suitable for in vivo and in vitro metabolism studies. Anal. Biochem. 306 (2002) 31-39
19. Repetto M.R., and Repetto M. Habitual, toxic and lethal concentrations of 103 drugs of abuse. J. Toxicol. Clin. Toxicol. 35 (1997) 1-9
20. Kintz P. Deaths involving buprenorphine: a compendium of French cases. Forensic Sci. Int. 121 (2001) 65-69
21. Parkinson A. Biotransformation of xenobiotics. In: Klaassen C.D. (Ed). Casarett and Doull's Toxicology: The Basic Science of Poisoning. 6th ed. (2001), Med Graw Hill Medical, New York 133-224
22. Elkader A., and Sproule B. Buprenorphine clinical pharmacokinetics in the treatment of opioid dependence. Clin. Pharmacokinet. 44 (2005) 661-680